Dr. Alkhaldi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
22 S Greene St
Rm N3E09
Baltimore, MD 21201Phone+1 410-328-6110
Education & Training
- University of MarylandResidency, Internal Medicine, 2016 - 2019
- OtherClass of 2012
Certifications & Licensure
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- CD19 CAR-T With Axicabtagene Ciloleucel in R/R Large B-Cell Lymphoma With/Without Prior Autologous Stem Cell Transplant.David T Chen, Olga Goloubeva, Aaron P Rapoport, Saurabh Dahiya, Djordje Atanackovic
Clinical Lymphoma, Myeloma & Leukemia. 2025-01-02 - Myeloablative Haploidentical Donor Hematopoietic Transplantation Using Post-Transplantation Cyclophosphamide and Antithymocyte Globulin.Riad El Fakih, Momen Nassani, Walid Rasheed, Amr Hanbali, Fahad Almohareb
Transplantation and Cellular Therapy. 2024-03-01 - 1 citationsHigh-Dose Chemotherapy and Autologous Stem Cell Transplantation for Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.Hanan Alkhaldi, Alec Reinhardt, Melissa Barnett, Suprateek Kundu, Chitra Hosing
Transplantation and Cellular Therapy. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: